Faeth Therapeutics (FTH) Total Liabilities (2020 - 2026)

Faeth Therapeutics (FTH) has reported Total Liabilities for 7 consecutive years, with $9.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 114.39% year-over-year to $9.6 million; the trailing twelve-month figure through Jun 2026 stood at $9.6 million (up 114.39% YoY), and the FY2025 full-year result was $4.3 million, down 38.21% from the prior year.
• Total Liabilities retreated to $9.6 million in Q2 2026 per FTH's latest filing, from $14.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $15.0 million in Q4 2022 and bottomed at $4.3 million in Q4 2025.
• Historically, Total Liabilities has averaged $9.7 million across 5 years, with a median of $9.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities jumped 356.89% in 2022, then sank 41.25% in 2025.
• Over 5 years, Total Liabilities stood at $15.0 million in 2022, then tumbled by 36.67% to $9.5 million in 2023, then decreased by 26.42% to $7.0 million in 2024, then sank by 38.21% to $4.3 million in 2025, then jumped by 122.3% to $9.6 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $9.6 million, $14.2 million, and $4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.